United States Capecitabine Fumarate Market Report 2017

January 2017 | 102 pages | ID: U230D48A90CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Capecitabine Fumarate

Revenue, means the sales value of Capecitabine Fumarate

This report studies sales (consumption) of Capecitabine Fumarate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Sun Pharma Global
• Pfizer
• Dr Reddys
• Mylan
• Sagent Pharms
• Akorn
• Emcure Pharms
• Hikma Farmaceutica
• Gland Pharma Ltd

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Oral
• Infusion

Split by applications, this report focuses on sales, market share and growth rate of Capecitabine Fumarate in each application, can be divided into

• Breast cancer
• Rectal cancer
• Colon cancer
• Gastric cancer
• Other malignancies

Contents

United States Capecitabine Fumarate Market Report 2017

1 CAPECITABINE FUMARATE OVERVIEW

1.1 Product Overview and Scope of Capecitabine Fumarate
1.2 Classification of Capecitabine Fumarate
  1.2.1 Oral
  1.2.2 Infusion
1.3 Application of Capecitabine Fumarate
  1.3.1 Breast cancer
  1.3.2 Rectal cancer
  1.3.3 Colon cancer
  1.3.4 Gastric cancer
  1.3.5 Other malignancies
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Capecitabine Fumarate (2011-2021)
  1.4.1 United States Capecitabine Fumarate Sales and Growth Rate (2011-2021)
  1.4.2 United States Capecitabine Fumarate Revenue and Growth Rate (2011-2021)

2 UNITED STATES CAPECITABINE FUMARATE COMPETITION BY MANUFACTURERS

2.1 United States Capecitabine Fumarate Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Capecitabine Fumarate Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Capecitabine Fumarate Average Price by Manufactures (2015 and 2016)
2.4 Capecitabine Fumarate Market Competitive Situation and Trends
  2.4.1 Capecitabine Fumarate Market Concentration Rate
  2.4.2 Capecitabine Fumarate Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CAPECITABINE FUMARATE SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Capecitabine Fumarate Sales and Market Share by States (2011-2016)
3.2 United States Capecitabine Fumarate Revenue and Market Share by States (2011-2016)
3.3 United States Capecitabine Fumarate Price by States (2011-2016)

4 UNITED STATES CAPECITABINE FUMARATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Capecitabine Fumarate Sales and Market Share by Type (2011-2016)
4.2 United States Capecitabine Fumarate Revenue and Market Share by Type (2011-2016)
4.3 United States Capecitabine Fumarate Price by Type (2011-2016)
4.4 United States Capecitabine Fumarate Sales Growth Rate by Type (2011-2016)

5 UNITED STATES CAPECITABINE FUMARATE SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Capecitabine Fumarate Sales and Market Share by Application (2011-2016)
5.2 United States Capecitabine Fumarate Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES CAPECITABINE FUMARATE MANUFACTURERS PROFILES/ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Capecitabine Fumarate Product Type, Application and Specification
    6.1.2.1 Oral
    6.1.2.2 Infusion
  6.1.3 Novartis Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Sun Pharma Global
  6.2.2 Capecitabine Fumarate Product Type, Application and Specification
    6.2.2.1 Oral
    6.2.2.2 Infusion
  6.2.3 Sun Pharma Global Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Capecitabine Fumarate Product Type, Application and Specification
    6.3.2.1 Oral
    6.3.2.2 Infusion
  6.3.3 Pfizer Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Dr Reddys
  6.4.2 Capecitabine Fumarate Product Type, Application and Specification
    6.4.2.1 Oral
    6.4.2.2 Infusion
  6.4.3 Dr Reddys Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Capecitabine Fumarate Product Type, Application and Specification
    6.5.2.1 Oral
    6.5.2.2 Infusion
  6.5.3 Mylan Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Sagent Pharms
  6.6.2 Capecitabine Fumarate Product Type, Application and Specification
    6.6.2.1 Oral
    6.6.2.2 Infusion
  6.6.3 Sagent Pharms Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Akorn
  6.7.2 Capecitabine Fumarate Product Type, Application and Specification
    6.7.2.1 Oral
    6.7.2.2 Infusion
  6.7.3 Akorn Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Emcure Pharms
  6.8.2 Capecitabine Fumarate Product Type, Application and Specification
    6.8.2.1 Oral
    6.8.2.2 Infusion
  6.8.3 Emcure Pharms Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Hikma Farmaceutica
  6.9.2 Capecitabine Fumarate Product Type, Application and Specification
    6.9.2.1 Oral
    6.9.2.2 Infusion
  6.9.3 Hikma Farmaceutica Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Gland Pharma Ltd
  6.10.2 Capecitabine Fumarate Product Type, Application and Specification
    6.10.2.1 Oral
    6.10.2.2 Infusion
  6.10.3 Gland Pharma Ltd Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview

7 CAPECITABINE FUMARATE MANUFACTURING COST ANALYSIS

7.1 Capecitabine Fumarate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Capecitabine Fumarate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Capecitabine Fumarate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Capecitabine Fumarate Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CAPECITABINE FUMARATE MARKET FORECAST (2016-2021)

11.1 United States Capecitabine Fumarate Sales, Revenue Forecast (2016-2021)
11.2 United States Capecitabine Fumarate Sales Forecast by Type (2016-2021)
11.3 United States Capecitabine Fumarate Sales Forecast by Application (2016-2021)
11.4 Capecitabine Fumarate Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Capecitabine Fumarate
Table Classification of Capecitabine Fumarate
Figure United States Sales Market Share of Capecitabine Fumarate by Type in 2015
Figure Oral Picture
Figure Infusion Picture
Table Application of Capecitabine Fumarate
Figure United States Sales Market Share of Capecitabine Fumarate by Application in 2015
Figure Breast cancer Examples
Figure Rectal cancer Examples
Figure Colon cancer Examples
Figure Gastric cancer Examples
Figure Other malignancies Examples
Figure United States Capecitabine Fumarate Sales and Growth Rate (2011-2021)
Figure United States Capecitabine Fumarate Revenue and Growth Rate (2011-2021)
Table United States Capecitabine Fumarate Sales of Key Manufacturers (2015 and 2016)
Table United States Capecitabine Fumarate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Capecitabine Fumarate Sales Share by Manufacturers
Figure 2016 Capecitabine Fumarate Sales Share by Manufacturers
Table United States Capecitabine Fumarate Revenue by Manufacturers (2015 and 2016)
Table United States Capecitabine Fumarate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Capecitabine Fumarate Revenue Share by Manufacturers
Table 2016 United States Capecitabine Fumarate Revenue Share by Manufacturers
Table United States Market Capecitabine Fumarate Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Capecitabine Fumarate Average Price of Key Manufacturers in 2015
Figure Capecitabine Fumarate Market Share of Top 3 Manufacturers
Figure Capecitabine Fumarate Market Share of Top 5 Manufacturers
Table United States Capecitabine Fumarate Sales by States (2011-2016)
Table United States Capecitabine Fumarate Sales Share by States (2011-2016)
Figure United States Capecitabine Fumarate Sales Market Share by States in 2015
Table United States Capecitabine Fumarate Revenue and Market Share by States (2011-2016)
Table United States Capecitabine Fumarate Revenue Share by States (2011-2016)
Figure Revenue Market Share of Capecitabine Fumarate by States (2011-2016)
Table United States Capecitabine Fumarate Price by States (2011-2016)
Table United States Capecitabine Fumarate Sales by Type (2011-2016)
Table United States Capecitabine Fumarate Sales Share by Type (2011-2016)
Figure United States Capecitabine Fumarate Sales Market Share by Type in 2015
Table United States Capecitabine Fumarate Revenue and Market Share by Type (2011-2016)
Table United States Capecitabine Fumarate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Capecitabine Fumarate by Type (2011-2016)
Table United States Capecitabine Fumarate Price by Type (2011-2016)
Figure United States Capecitabine Fumarate Sales Growth Rate by Type (2011-2016)
Table United States Capecitabine Fumarate Sales by Application (2011-2016)
Table United States Capecitabine Fumarate Sales Market Share by Application (2011-2016)
Figure United States Capecitabine Fumarate Sales Market Share by Application in 2015
Table United States Capecitabine Fumarate Sales Growth Rate by Application (2011-2016)
Figure United States Capecitabine Fumarate Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Capecitabine Fumarate Sales Market Share (2011-2016)
Table Sun Pharma Global Basic Information List
Table Sun Pharma Global Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharma Global Capecitabine Fumarate Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Capecitabine Fumarate Sales Market Share (2011-2016)
Table Dr Reddys Basic Information List
Table Dr Reddys Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr Reddys Capecitabine Fumarate Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Capecitabine Fumarate Sales Market Share (2011-2016)
Table Sagent Pharms Basic Information List
Table Sagent Pharms Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sagent Pharms Capecitabine Fumarate Sales Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akorn Capecitabine Fumarate Sales Market Share (2011-2016)
Table Emcure Pharms Basic Information List
Table Emcure Pharms Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emcure Pharms Capecitabine Fumarate Sales Market Share (2011-2016)
Table Hikma Farmaceutica Basic Information List
Table Hikma Farmaceutica Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hikma Farmaceutica Capecitabine Fumarate Sales Market Share (2011-2016)
Table Gland Pharma Ltd Basic Information List
Table Gland Pharma Ltd Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gland Pharma Ltd Capecitabine Fumarate Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Capecitabine Fumarate
Figure Manufacturing Process Analysis of Capecitabine Fumarate
Figure Capecitabine Fumarate Industrial Chain Analysis
Table Raw Materials Sources of Capecitabine Fumarate Major Manufacturers in 2015
Table Major Buyers of Capecitabine Fumarate
Table Distributors/Traders List
Figure United States Capecitabine Fumarate Production and Growth Rate Forecast (2016-2021)
Figure United States Capecitabine Fumarate Revenue and Growth Rate Forecast (2016-2021)
Table United States Capecitabine Fumarate Production Forecast by Type (2016-2021)
Table United States Capecitabine Fumarate Consumption Forecast by Application (2016-2021)
Table United States Capecitabine Fumarate Sales Forecast by States (2016-2021)
Table United States Capecitabine Fumarate Sales Share Forecast by States (2016-2021)